Long-term outcomes for HIV-infected infants less than 6 months of age at initiation of lopinavir/ritonavir combination antiretroviral therapy

OBJECTIVE: To investigate the longitudinal pharmacokinetics, safety and efficacy of lopinavir/ritonavir (LPV/r) in HIV-infected infants initiating combination antiretroviral therapy (cART) between 2 weeks and 6 months of age. METHOD: A prospective, open-label, multicenter Phase I/II study of LPV/r-b...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Chadwick, Ellen G., Yogev, Ram, Alvero, Carmelita G., Hughes, Michael D., Hazra, Rohan, Pinto, Jorge A., Robbins, Brian L., Heckman, Barbara E., Palumbo, Paul E., Capparelli, Edmund V.
Formato: Artigo
Idioma:Inglês
Publicado: 2011
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3068474/
https://ncbi.nlm.nih.gov/pubmed/21297419
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0b013e32834403f6
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares